We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+12.47%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.13B
AUM Growth
+$203M
Cap. Flow
-$12.1M
Cap. Flow %
-0.57%
Top 10 Hldgs %
30.3%
Holding
2,428
New
30
Increased
109
Reduced
927
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 24.26%
2 Financials 10.88%
3 Healthcare 10.85%
4 Consumer Discretionary 9.35%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRBS icon
2351
Blue Ridge Bankshares
BRBS
$339M
-848
Closed -$3.83K
BW icon
2352
Babcock & Wilcox
BW
$1.44B
-3,279
Closed -$13.8K
CARM
2353
DELISTED
Carisma Therapeutics
CARM
-1,470
Closed -$6.22K
CATO icon
2354
Cato Corp
CATO
$66.7M
-1,016
Closed -$7.78K
CCRD
2355
DELISTED
CoreCard
CCRD
-399
Closed -$7.98K
COOK icon
2356
Traeger
COOK
$172M
-42
Closed -$5.69K
DHX icon
2357
DHI Group
DHX
$171M
-2,295
Closed -$7.02K
DXC icon
2358
DXC Technology
DXC
$1.74B
-8,488
Closed -$177K
EBS icon
2359
Emergent Biosolutions
EBS
$236M
-2,773
Closed -$9.43K
EVEX icon
2360
Eve Holding
EVEX
$965M
-1,051
Closed -$8.71K
EVI icon
2361
EVI Industries
EVI
$212M
-279
Closed -$6.92K
FHTX icon
2362
Foghorn Therapeutics
FHTX
$393M
-1,295
Closed -$6.47K
GBIO
2363
DELISTED
Generation Bio
GBIO
-266
Closed -$10.1K
GORV
2364
DELISTED
Lazydays
GORV
-23
Closed -$5.35K
GWH icon
2365
ESS Tech
GWH
$19.7M
-367
Closed -$10.3K
HYLN icon
2366
Hyliion Holdings
HYLN
$809M
-7,892
Closed -$9.31K
INNV icon
2367
InnovAge Holding
INNV
$1.45B
-1,260
Closed -$7.55K
JILL icon
2368
J. Jill
JILL
$280M
-273
Closed -$8.08K
KPTI icon
2369
Karyopharm Therapeutics
KPTI
$44.9M
-416
Closed -$8.36K
LCTX icon
2370
Lineage Cell Therapeutics
LCTX
$273M
-7,125
Closed -$8.41K
LNZA icon
2371
LanzaTech
LNZA
$66.5M
-12
Closed -$5.72K
LXRX icon
2372
Lexicon Pharmaceuticals
LXRX
$1.06B
-4,595
Closed -$5.01K
MCRB icon
2373
Seres Therapeutics
MCRB
$47.7M
-267
Closed -$12.7K
NOTE
2374
DELISTED
FiscalNote
NOTE
-301
Closed -$7.5K
OGN icon
2375
Organon & Co
OGN
$3.59B
-10,573
Closed -$184K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2023 Portfolio in Review

As of Q4 2023, Metropolitan Life Insurance Company (MetLife) held 2,428 positions worth $2.13B, up 11% from $1.93B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 4.7%. Metropolitan Life Insurance Company (MetLife) opened 30 new positions and exited 85, leaving the 2,428-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2023 buy was iShares Broad USD Investment Grade Corporate Bond ETF: 578,568 shares worth $29.7M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Core US Aggregate Bond ETF in Q4 2023, an estimated $38.1M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2023 reduction was Apple, cutting an estimated $2.39M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Vanguard Total Bond Market in Q4 2023, selling an estimated $72.5M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 30% of its $2.13B portfolio in Q4 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 30 new positions and closed 85 in Q4 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 11% quarter-over-quarter to $2.13B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.